Sharma, Kumar, M.D.赞助的临床试验
总计208个结果
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC终止
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC完全的
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC完全的
-
King, David, MDMERZ PHARMA尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma Inc完全的既往骨髓增生异常综合征引起的急性髓性白血病 | 慢性粒单核细胞白血病 | 先前治疗过的骨髓增生异常综合征 | 复发性成人急性髓性白血病 | 骨髓增生异常综合症 | 成人急性髓性白血病伴 Inv(16)(p13.1q22); CBFB-MYH11 | 成人急性髓系白血病伴 t(16;16)(p13.1;q22); CBFB-MYH11 | 成人急性髓系白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | 成人急性髓性白血病伴 t(9;11)(p22.3;q23.3); MLLT3-KMT2A | 烷化剂相关的急性髓性白血病 | 伴有 PML-RARA 的成人急性早幼粒细胞白血病美国
-
M.D. Anderson Cancer CenterBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完全的
-
ElTyeb, Sara Amir Hassan, M.D.Sudan Medical Specialization Board (SMSB); Elfatih Malik, MD完全的发育障碍
-
M.D. Anderson Cancer CenterKite, A Gilead Company; Acerta Pharma, LLC招聘中
-
M.D. Anderson Cancer CenterAstellas Pharma Inc; The Kadoorie Charitable Foundations招聘中
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; AstraZeneca主动,不招人
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene主动,不招人
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; InSightec尚未招聘
-
Marvin W. Kronenberg, M.D.Astellas Pharma US, Inc.完全的
-
Anandasabapathy, Sharmila, M.D.Icahn School of Medicine at Mount Sinai完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astellas Pharma US, Inc.完全的
-
Anandasabapathy, Sharmila, M.D.Baylor College of Medicine; William Marsh Rice University未知
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.招聘中
-
Michael Muldoon, M.D.The Methodist Hospital Research Institute撤销
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene Corporation完全的
-
Anandasabapathy, Sharmila, M.D.Baylor College of Medicine; William Marsh Rice University未知
-
Mark Garzotto, MDMerck Sharp & Dohme LLC; Astellas Pharma Inc招聘中
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte Ltd招聘中
-
Nasser Hanna, M.D.Merck Sharp & Dohme LLC; Hoosier Cancer Research Network终止生殖器肿瘤,女性 | 睾丸肿瘤 | 生殖器肿瘤,男性 | 卵巢肿瘤 | 纵隔肿瘤 | 生殖细胞肿瘤 | 非精原细胞瘤美国
-
Nasser Hanna, M.D.Merck Sharp & Dohme LLC; Hoosier Cancer Research Network完全的
-
Jair Bar, M.D., Ph.D.Merck Sharp & Dohme LLC完全的
-
April Salama, M.D.Merck Sharp & Dohme LLC; Olatec Therapeutics LLC招聘中
-
RenJi HospitalNitto Denko Corporation; Giant Med-Pharma Services Inc.未知
-
Inna Chen, MDRoche Pharma AG招聘中
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; InterMune; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma完全的
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; BioMed Valley Discoveries, Inc主动,不招人女性生殖器恶性肿瘤 | 乳腺恶性肿瘤 | 不明确的次要和未指定部位的恶性肿瘤 | 唇口咽部恶性肿瘤 | 独立(原发)多部位恶性肿瘤 | 间皮和软组织恶性肿瘤 | 甲状腺和其他内分泌腺恶性肿瘤 | 泌尿系恶性肿瘤 | 消化器官恶性肿瘤 | 男性生殖器恶性肿瘤 | 眼脑及中枢神经系统其他部位的恶性肿瘤 | 呼吸系统和胸腔内器官恶性肿瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLC完全的
-
Indiana University School of MedicineRoche Pharma AG; Facet Biotech; Pescovitz, Mark D., M.D.完全的
-
Doroana, Maria Manuela, M.D.Merck Sharp & Dohme LLC; Eurotrials Brasil Consultores Cientificos Ltda完全的
-
Jacob Soumerai, MDMEI Pharma, Inc.撤销
-
Andrew Hendifar, MDEOC Pharma主动,不招人